DFO
CBST

Duquesne Family Office’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Duquesne Family Office’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-413,000
Closed -$28.4M – 52
2013
Q4 		$28.4M Hold
413,000
– – 1.9% 21
2013
Q3 		$26.2M Hold
413,000
– – 3.1% 11
2013
Q2 		$19.9M Buy
+413,000
New +$20.3M 2.96% 10

Other funds holding CBST

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Duquesne Family Office's CBST Position: Q1 2014 in Review

Duquesne Family Office sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2014, closing a stake of 413,000 shares — an estimated $28.4M sold.

Duquesne Family Office first reported a position in CBST in Q2 2013 and held it in 3 quarters. The position peaked at $28.4M in Q4 2013. 276 funds tracked by Wall St. Rank hold CBST as of Q1 2014.

  • Duquesne Family Office reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Duquesne Family Office sold 413,000 CUBIST PHARMACEUTICALS INC shares in Q1 2014, an estimated $28.4M.
  • Duquesne Family Office first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 3 quarters.
  • Duquesne Family Office's CUBIST PHARMACEUTICALS INC position peaked at $28.4M in Q4 2013.
  • 276 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2014.

Based on Duquesne Family Office's 13F filing for Q1 2014, filed 14 May 2014.